Literature DB >> 22207732

Peroxisome proliferator-activated receptor-γ activation induces 11β-hydroxysteroid dehydrogenase type 1 activity in human alternative macrophages.

Giulia Chinetti-Gbaguidi1, Mohamed Amine Bouhlel, Corinne Copin, Christian Duhem, Bruno Derudas, Bernadette Neve, Benoit Noel, Jerome Eeckhoute, Philippe Lefebvre, Jonathan R Seckl, Bart Staels.   

Abstract

OBJECTIVE: 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) catalyzes the intracellular reduction of inactive cortisone to active cortisol, the natural ligand activating the glucocorticoid receptor (GR). Peroxisome proliferator- activated receptor-γ (PPARγ) is a nuclear receptor controlling inflammation, lipid metabolism, and the macrophage polarization state. In this study, we investigated the impact of macrophage polarization on the expression and activity of 11β-HSD1 and the role of PPARγ therein. METHODS AND
RESULTS: 11β-HSD1 gene expression is higher in proinflammatory M1 and anti-inflammatory M2 macrophages than in resting macrophages, whereas its activity is highest in M2 macrophages. Interestingly, PPARγ activation induces 11β-HSD1 enzyme activity in M2 macrophages but not in resting macrophages or M1 macrophages. Consequently, human M2 macrophages displayed enhanced responsiveness to the 11β-HSD1 substrate cortisone, an effect amplified by PPARγ induction of 11β-HSD1 activity, as illustrated by an increased expression of GR target genes.
CONCLUSION: Our data identify a positive cross-talk between PPARγ and GR in human M2 macrophages via the induction of 11β-HSD1 expression and activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22207732      PMCID: PMC3428270          DOI: 10.1161/ATVBAHA.111.241364

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  32 in total

Review 1.  The PPARs: from orphan receptors to drug discovery.

Authors:  T M Willson; P J Brown; D D Sternbach; B R Henke
Journal:  J Med Chem       Date:  2000-02-24       Impact factor: 7.446

2.  The human ABCG4 gene is regulated by oxysterols and retinoids in monocyte-derived macrophages.

Authors:  T Engel; S Lorkowski; A Lueken; S Rust; B Schlüter; G Berger; P Cullen; G Assmann
Journal:  Biochem Biophys Res Commun       Date:  2001-10-26       Impact factor: 3.575

Review 3.  Alternative activation of macrophages.

Authors:  Siamon Gordon
Journal:  Nat Rev Immunol       Date:  2003-01       Impact factor: 53.106

Review 4.  Macrophage polarization in metabolic disorders: functions and regulation.

Authors:  Giulia Chinetti-Gbaguidi; Bart Staels
Journal:  Curr Opin Lipidol       Date:  2011-10       Impact factor: 4.776

5.  The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors.

Authors:  C A Beck; P A Estes; B J Bona; C A Muro-Cacho; S K Nordeen; D P Edwards
Journal:  Endocrinology       Date:  1993-08       Impact factor: 4.736

6.  Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.

Authors:  Lisa M Leesnitzer; Derek J Parks; Randy K Bledsoe; Jeff E Cobb; Jon L Collins; Thomas G Consler; Roderick G Davis; Emily A Hull-Ryde; James M Lenhard; Lisa Patel; Kelli D Plunket; Jennifer L Shenk; Julie B Stimmel; Christina Therapontos; Timothy M Willson; Steven G Blanchard
Journal:  Biochemistry       Date:  2002-05-28       Impact factor: 3.162

7.  A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.

Authors:  S A Kliewer; J M Lenhard; T M Willson; I Patel; D C Morris; J M Lehmann
Journal:  Cell       Date:  1995-12-01       Impact factor: 41.582

8.  'Liver-type' 11 beta-hydroxysteroid dehydrogenase cDNA encodes reductase but not dehydrogenase activity in intact mammalian COS-7 cells.

Authors:  S C Low; K E Chapman; C R Edwards; J R Seckl
Journal:  J Mol Endocrinol       Date:  1994-10       Impact factor: 5.098

Review 9.  Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications.

Authors:  G Chinetti; J-C Fruchart; B Staels
Journal:  Int J Obes Relat Metab Disord       Date:  2003-12

10.  ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.

Authors:  Nan Wang; Debin Lan; Wengen Chen; Fumihiko Matsuura; Alan R Tall
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

View more
  15 in total

1.  Pioglitazone in adult rats reverses immediate postnatal overfeeding-induced metabolic, hormonal, and inflammatory alterations.

Authors:  S Boullu-Ciocca; V Tassistro; A Dutour; M Grino
Journal:  Endocrine       Date:  2015-06-18       Impact factor: 3.633

2.  Macrophages Protect Endometriotic Cells Against Oxidative Damage Through a Cross-Talk Mechanism.

Authors:  Kenji Ogawa; Tingting Liu; Naoki Kawahara; Hiroshi Kobayashi
Journal:  Reprod Sci       Date:  2022-02-23       Impact factor: 2.924

3.  Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism.

Authors:  Tara C Brennan-Speranza; Holger Henneicke; Sylvia J Gasparini; Katharina I Blankenstein; Uta Heinevetter; Victoria C Cogger; Dmitri Svistounov; Yaqing Zhang; Gregory J Cooney; Frank Buttgereit; Colin R Dunstan; Caren Gundberg; Hong Zhou; Markus J Seibel
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

4.  The effect of pioglitazone on aldosterone and cortisol production in HAC15 human adrenocortical carcinoma cells.

Authors:  Zhi-qiang Pan; Ding Xie; Vivek Choudhary; Mutsa Seremwe; Ying-Ying Tsai; Lawrence Olala; Xunsheng Chen; Wendy B Bollag
Journal:  Mol Cell Endocrinol       Date:  2014-07-17       Impact factor: 4.102

Review 5.  11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

Authors:  Karen Chapman; Megan Holmes; Jonathan Seckl
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

Review 6.  Changing glucocorticoid action: 11β-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation.

Authors:  Karen E Chapman; Agnes E Coutinho; Zhenguang Zhang; Tiina Kipari; John S Savill; Jonathan R Seckl
Journal:  J Steroid Biochem Mol Biol       Date:  2013-02-19       Impact factor: 4.292

7.  PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors.

Authors:  Jerzy Kotlinowski; Anna Grochot-Przeczek; Hevidar Taha; Magdalena Kozakowska; Bartosz Pilecki; Klaudia Skrzypek; Aleksandra Bartelik; Rafal Derlacz; Anton J G Horrevoets; Attila Pap; Laszlo Nagy; Jozef Dulak; Alicja Jozkowicz
Journal:  Cardiovasc Diabetol       Date:  2014-11-01       Impact factor: 9.951

8.  Peroxisome Proliferator-Activated Receptor γ Induces the Expression of Tissue Factor Pathway Inhibitor-1 (TFPI-1) in Human Macrophages.

Authors:  G Chinetti-Gbaguidi; C Copin; B Derudas; N Marx; J Eechkoute; B Staels
Journal:  PPAR Res       Date:  2016-12-27       Impact factor: 4.964

9.  11β-Hydroxysteroid Dehydrogenase Type 1 Is Expressed in Neutrophils and Restrains an Inflammatory Response in Male Mice.

Authors:  Agnes E Coutinho; Tiina M J Kipari; Zhenguang Zhang; Cristina L Esteves; Christopher D Lucas; James S Gilmour; Scott P Webster; Brian R Walker; Jeremy Hughes; John S Savill; Jonathan R Seckl; Adriano G Rossi; Karen E Chapman
Journal:  Endocrinology       Date:  2016-05-04       Impact factor: 4.736

10.  Macrophage 11β-HSD-1 deficiency promotes inflammatory angiogenesis.

Authors:  Zhenguang Zhang; Agnes E Coutinho; Tak Yung Man; Tiina M J Kipari; Patrick W F Hadoke; Donald M Salter; Jonathan R Seckl; Karen E Chapman
Journal:  J Endocrinol       Date:  2017-07-04       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.